Blue Owl Capital Holdings’s MoonLake Immunotherapeutics MLTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-100,000	Closed	-$5.02M	–	50
2024 Q1	$5.02M	Buy	100,000 +35,000	+54%	+$1.76M	1%	22
2023 Q4	$3.93M	Buy	+65,000	New	+$3.93M	0.94%	21